Literature DB >> 5925315

Studies of PPLO infection. IV. The neurotoxicity of intact mycoplasmas, and their production of toxin in vivo and in vitro.

L Thomas, M W Bitensky.   

Abstract

Concentrated suspensions of washed Mycoplasma neurolyticum produce rolling disease in mice and rats, with neurological manifestations and pathological lesions similar to those seen with the exotoxin of this organism. Pretreatment of animals with tetracycline protects completely against the toxic effects of washed suspensions of mycoplasmas, while tetracycline affords no protection against the exotoxin. Freeze-thawing disruption of mycoplasma suspensions eliminates their neurotoxicity, while the same treatment does not affect exotoxin. The toxicity of intact organisms is not affected by exposure to the sedimentable component of brain, nor to ganglioside. These observations are interpreted to indicate that the neurotoxicity of living mycoplasmas must be due to their production of toxin after they have been injected into the animal. Resting mycoplasmas, suspended in Ringer's solution in dialysis sacs submerged in PPLO broth) produce considerable amounts of toxin within 15 min of incubation at 37 degrees C. Toxin is also produced, although in somewhat less amount, by washed organisms suspended in phosphate buffer containing glucose. The formation of toxin is prevented by the presence of puromycin, but not by the aminonucleoside analogue of puromycin, indicating that active protein synthesis is involved in the elaboration of toxin. The similarities between the neurotoxicity of the intact organisms of M. neurolyticum and Mycoplasma gallisepticum are discussed.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5925315      PMCID: PMC2138334          DOI: 10.1084/jem.124.6.1089

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  5 in total

1.  Structural requirements for puromycin inhibition of protein synthesis.

Authors:  D NATHANS; A NEIDLE
Journal:  Nature       Date:  1963-03-16       Impact factor: 49.962

2.  ISOLATION OF A FILTRABLE, TRANSMISSIBLE AGENT WITH "NEUROLYTI" PROPERTIES FROM TOXOPLASMA-INFECTED TISSUES.

Authors:  A B Sabin
Journal:  Science       Date:  1938-08-26       Impact factor: 47.728

3.  PRODUCTION AND BIOLOGICAL CHARACTERISTICS OF AN EXTRACELLULAR NEUROTOXIN FROM MYCOPLASMA NEUROLYTICUM.

Authors:  J G TULLY
Journal:  J Bacteriol       Date:  1964-08       Impact factor: 3.490

4.  Studies of PPLO infection. II. The neurotoxin of Mycoplasma neurolyticum.

Authors:  L Thomas; F Aleu; M W Bitensky; M Davidson; B Gesner
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

5.  Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis.

Authors:  J R David
Journal:  J Exp Med       Date:  1965-12-01       Impact factor: 14.307

  5 in total
  6 in total

1.  Mycoplasma pneumoniae protein involved in the antibody response in human infection.

Authors:  S Räisänen; J I Suni; A Vaheri
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

2.  Occlusion of brain capillaries by endothelial swelling in mycoplasma infections.

Authors:  E E Manuelidis; L Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

3.  Immunological response of rodents to murine mycoplasmas.

Authors:  B C Cole; L Golightly-Rowland; J R Ward; B B Wiley
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

4.  Pathogenicity of Mycoplasma pulmonis in ependymal organ culture.

Authors:  D F Kohn; N Chinookoswong
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

5.  Mycoplasmas as pathogens.

Authors:  L Thomas
Journal:  Yale J Biol Med       Date:  1968 Apr-Jun

6.  Comparison of mitogens from Mycoplasma pulmonis and Mycoplasma neurolyticum.

Authors:  R Katz; R Siman-Tov; Y Naot
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.